Find More Profitable Top Gainers Stock ( RFIL, RGEN, FRO, CTIC )

Los Angelas, CA -- (SBWIRE) -- 09/11/2012 -- RF Industries, Lt (NGM:RFIL) is +0.49 - +12.25% from the previous close of $4.00. It traded between $4.20 - 4.98 with total traded volume of 170680 shares. Keep a close eye on RFIL, as the stock has been showing unusual moves over the past weeks. At Current market price, RFIL has recovered +55.36% from its 52-week Low of 2.89 and has Pulled back -9.84% from its 52-week high of 4.98. RF Industries Ltd. : Approximately 170,300 shares changed hands, a 2,519.9 percent increase over its 65-day average volume. The shares rose $.49 or 12.3 percent to $4.49. RF INDUSTRIES, LTD. (RFIL) today announced record quarterly sales and consolidated net income for the third quarter ended July 31, 2012. Net sales increased 51% to a quarterly record $7,472,000 compared to $4,948,000 in the same quarter last year. Consolidated net income was a quarterly record $735,000, or $0.10 per diluted share, compared to consolidated net income of $65,000, or $0.01 per diluted share in the same quarter last year.

Free Sign Ups Here To Know More About RFIL Daily

Repligen Corporat (NGM:RGEN) is +0.65 - +12.10% from the previous close of $5.37. It traded between $5.80 - 6.18 with total traded volume of 607932 shares. Keep a close eye on RGEN, as the stock has been showing unusual moves over the past weeks. At Current market price, RGEN has recovered +107.59% from its 52-week Low of 2.90 and has Pulled back -17.42% from its 52-week high of 7.29. CFO William J. Kelly sold 95,000 shares of RGEN stock on 08/31/2012 at the average price of $5.52. The price of the stock has decreased by 2.72% since. Repligen Corporation develops new drugs based on naturally occurring peptides and proteins for autism, organ transplantation and immunesystem diseases. Repligen Corporation has a market cap of $175.5 million; its shares were traded at around $5.37 with a P/E ratio of 142.3 and P/S ratio of 6.4.

To Know More About RGEN Click Here Daily

Frontline Ltd. Or (NYSE:FRO) is very active today and traded between $3.331 - 3.84 with total traded volume of 1471943 shares. At a current price of 3.79, FRO is +0.38 - +11.14% from the previous close of $3.41. Moreover, At Current Market Price, FRO is in distance of +4.84% from its 50-day Moving Average price of $3.6149 and -23.97% from its 200-day Moving Average price of $4.9848. The shipping industry remains mired in oversupply thanks to terrible industry economics. Though shipping rates recovered a bit in 2010 and 2011, the Baltic Dry Index has tumbled this year to near all-time lows. Management indicated that fleet growth should come to a standstill by the end of 2013, but orders (though slowing) are still coming in for new Suezmax vessels. If economic growth in China continues to slow, we expect an ongoing dislocation between supply and demand beyond 2013.

Free Sign Ups Here To Know More About FRO Daily

Cell Therapeutics (NCM:CTIC) is +0.25 - +10.78% from the previous close of $2.32. It traded between $2.37 - 2.67 with total traded volume of 2814241 shares. Keep a close eye on CTIC, as the stock has been showing unusual moves over the past weeks. At Current market price, CTIC has recovered +45.20% from its 52-week Low of 1.77 and has Pulled back -68.85% from its 52-week high of 8.25. Cell Therapeutics (CTIC) is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. Cell Therapeutics announced on September 7 that it will update Pixuvri launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. EST.

Free Sign Ups Here To Know More About CTIC Daily

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com